Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole

Background  Griseofulvin has been the mainstay of treatment for tinea imbricata (TI) for decades; however, there have been few reports of efficacy of newer antifungals in the treatment of this condition. Many patients with TI have several obstacles to treatment due to their remote geographical locations and the primitive nature of their societies.

[1]  J. Aguado,et al.  [Systemic antifungal agents]. , 2003, Enfermedades infecciosas y microbiologia clinica.

[2]  P. Widjanarko,et al.  A double‐blind, randomized, stratified controlled study of the treatment of tinea imbricata with oral terbinafine or itraconazole , 1994, The British journal of dermatology.

[3]  R. Logan,et al.  Tinea imbricata in a British nurse , 1988, Clinical and experimental dermatology.

[4]  R. Hay Tinea Imbricata , 1985, International journal of dermatology.

[5]  R. Hay,et al.  Endemic tinea imbricata--a study on Goodenough Island, Papua New Guinea. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[6]  R. Hay,et al.  Antibody responses in tinea imbricata: the role of immunoglobulin E. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  R. Hay,et al.  Immune responses of patients with tinea imbricata , 1983, The British journal of dermatology.

[8]  M. Alpers,et al.  Genetic inheritance of susceptibility to tinea imbricata. , 1980, Journal of medical genetics.

[9]  R. Dobson,et al.  British Association of Dermatologists , 2014 .

[10]  S. Serjeantson,et al.  AUTOSOMAL RECESSIVE INHERITANCE OF SUSCEPTIBILITY TO TINEA IMBRICATA , 1977, The Lancet.

[11]  V. Shah,et al.  Griseofulvin levels in stratum corneum. Study after oral administration in man. , 1972, Archives of dermatology.

[12]  C. Halde,et al.  Tinea imbricata treated with griseofulvin. , 1965, The American journal of tropical medicine and hygiene.

[13]  R. NUNEZ ANDRADE [Tinea imbricata]. , 1953, Medicina.